Abstract

BackgroundPalivizumab is a monoclonal antibody that provides passive immunity against respiratory syncytial virus (RSV) and has very specific criteria for use that have changed recently. According to the literature data,...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
RSV prevention in infancy and asthma in later life
Xavier Carbonell-Estrany
The Lancet Respiratory Medicine | VOL. 6
Xavier Carbonell-EstranyXavier Carbonell-Estrany
22 Jun 2018
Incidence of Bronchiolitis-Associated Hospitalization Among Children in Olmsted County, Minnesota
Thomas G Boyce ... Jennifer L St Sauver
Mayo Clinic Proceedings | VOL. 79
Thomas G Boyce, et. al.Thomas G Boyce ... Jennifer L St Sauver
01 Jun 2004
Respiratory syncytial virus and palivizumab: Where are we in 2014?
Joan Robinson
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale | VOL. 25
Joan RobinsonJoan Robinson
01 Jan 2014
A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant.
Bali Zhao ... Shibo Jiang
Cell Reports | VOL. 36
Bali Zhao, et. al.Bali Zhao ... Shibo Jiang
01 Jul 2021
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
A single harmonised pharmacy process to improve clinical trial set-up times
Miriam Lettieri ... Beatriz Duran Jimenez
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Miriam Lettieri, et. al.Miriam Lettieri ... Beatriz Duran Jimenez
27 Jun 2024
Potential medicine waste in the process of outpatients receiving cost-free medicines from medicine pick-up lockers in the North Denmark region
Lisa Greve Routhe ... Anne Estrup Olesen
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Lisa Greve Routhe, et. al.Lisa Greve Routhe ... Anne Estrup Olesen
26 Jun 2024
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients
Yan Yan ... Ji Wu
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Yan Yan, et. al.Yan Yan ... Ji Wu
19 Jun 2024
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK
Stephen Morris ... Andrew Salm
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Stephen Morris, et. al.Stephen Morris ... Andrew Salm
14 Jun 2024
View more papers